Morgan Stanley’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-464,630
Closed -$31.6M 8178
2022
Q3
$31.6M Sell
464,630
-391,669
-46% -$26.7M ﹤0.01% 1712
2022
Q2
$27.4M Buy
856,299
+287,760
+51% +$9.19M ﹤0.01% 1942
2022
Q1
$19.7M Buy
568,539
+367,681
+183% +$12.7M ﹤0.01% 2130
2021
Q4
$5.88M Sell
200,858
-110,385
-35% -$3.23M ﹤0.01% 3548
2021
Q3
$7.93M Sell
311,243
-238,739
-43% -$6.08M ﹤0.01% 3176
2021
Q2
$19.3M Buy
549,982
+374,402
+213% +$13.1M ﹤0.01% 2192
2021
Q1
$7.16M Sell
175,580
-97,327
-36% -$3.97M ﹤0.01% 3028
2020
Q4
$11.8M Buy
272,907
+163,515
+149% +$7.08M ﹤0.01% 2329
2020
Q3
$6.03M Buy
109,392
+25,373
+30% +$1.4M ﹤0.01% 2532
2020
Q2
$5.3M Sell
84,019
-317,832
-79% -$20.1M ﹤0.01% 2599
2020
Q1
$20.5M Buy
401,851
+149,473
+59% +$7.64M 0.01% 1256
2019
Q4
$20.1M Buy
252,378
+131,950
+110% +$10.5M ﹤0.01% 1657
2019
Q3
$5.84M Sell
120,428
-35,644
-23% -$1.73M ﹤0.01% 2694
2019
Q2
$8.21M Sell
156,072
-5,732
-4% -$302K ﹤0.01% 2368
2019
Q1
$8.57M Sell
161,804
-89,077
-36% -$4.72M ﹤0.01% 2180
2018
Q4
$10.3M Sell
250,881
-33,501
-12% -$1.38M ﹤0.01% 2097
2018
Q3
$10.8M Buy
284,382
+35,878
+14% +$1.36M ﹤0.01% 2326
2018
Q2
$11.2M Sell
248,504
-126,743
-34% -$5.73M ﹤0.01% 2240
2018
Q1
$18.1M Buy
375,247
+61,336
+20% +$2.96M 0.01% 1759
2017
Q4
$12.4M Sell
313,911
-113,577
-27% -$4.47M ﹤0.01% 2184
2017
Q3
$13.3M Sell
427,488
-80
-0% -$2.48K ﹤0.01% 1999
2017
Q2
$11.7M Buy
427,568
+92,696
+28% +$2.54M ﹤0.01% 2028
2017
Q1
$12.3M Buy
334,872
+195,323
+140% +$7.2M ﹤0.01% 1996
2016
Q4
$2.02M Buy
139,549
+112,159
+409% +$1.62M ﹤0.01% 3923
2016
Q3
$631K Sell
27,390
-45,482
-62% -$1.05M ﹤0.01% 4378
2016
Q2
$1.21M Buy
72,872
+35,593
+95% +$591K ﹤0.01% 3831
2016
Q1
$591K Buy
37,279
+34,318
+1,159% +$544K ﹤0.01% 4317
2015
Q4
$96K Sell
2,961
-83,096
-97% -$2.69M ﹤0.01% 5430
2015
Q3
$3.63M Buy
+86,057
New +$3.63M ﹤0.01% 2936